Forbion is a prominent European venture capital company that assists enterprises in bridging the gap between research and development with its team's proficiency in pharmaceutical advancement and business establishment. Forbion is a supporter of the United Nations Principles for Responsible Investment, further showcasing our belief that investments in businesses should have a positive influence on the health and welfare of patients. Forbion has made significant contributions to the well-being of patients on a global scale. Our portfolio companies have had a constructive impact on nearly half a million patients in various sectors.